Evidence map›Paper›PMID 23480958›Full record

ArticleBiomaterials2013

The modulation of endothelial cell morphology, function, and survival using anisotropic nanofibrillar collagen scaffolds.

Ngan F Huang, Janet Okogbaa, Jerry C Lee, Arshi Jha, Tatiana S Zaitseva, Michael V Paukshto, John S Sun, Niraj Punjya, Gerald G Fuller, John P Cooke

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Etiology and treatment of cancer-related secondary lymphedema.Clinical & experimental metastasis · 2024
    Review
  7. Review
  8. Review
  9. Bioengineering Cell Therapy for Treatment of Peripheral Artery Disease.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering.Journal of cardiovascular development and disease · 2021
    Review
  16. Review
  17. Review
  18. Keratocyte mechanobiology.Experimental eye research · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ngan F HuangDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA; Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, CA 94304, USA; The Cardiovascular Institute, Stanford, CA, USA.
Janet OkogbaaDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Jerry C LeeDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Arshi JhaDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Tatiana S ZaitsevaFibralign Corp, Sunnyvale, CA, USA.
Michael V PaukshtoFibralign Corp, Sunnyvale, CA, USA.
John S SunDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Niraj PunjyaDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Gerald G FullerDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA.
John P CookeDivision of Cardiovascular Medicine, Stanford University, Stanford, CA, USA; The Cardiovascular Institute, Stanford, CA, USA. Electronic address: john.cooke@stanford.edu.
Stanford University · USFibralign (United States) · USVA Palo Alto Health Care System · US

Funding

Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
Stanford Career Development in Vascular MedicineK12HL087746 · NHLBI · STANFORD UNIVERSITY · PI DALMAN, RONALD L · 2007 to 2012
$3.5M
NCE-based strategy for nuclear reprogramming and regenerative medicineRC2HL103400 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2010
$2.7M
Matrix-mediated endothelial differentiation of induced pluripotent stem cellsR00HL098688 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI HUANG, NGAN F. · 2013 to 2016
$742k
Matrix-mediated endothelial differentiation of induced pluripotent stem cellsK99HL098688 · NHLBI · STANFORD UNIVERSITY · PI HUANG, NGAN F. · 2010 to 2011
$266k
NHLBI NIH HHS 1K12HL087746NHLBI NIH HHS HL098688NHLBI NIH HHS K12 HL087746NHLBI NIH HHS K99 HL098688NHLBI NIH HHS R00 HL098688NHLBI NIH HHS RC2 HL103400NHLBI NIH HHS RC2HL103400NHLBI NIH HHS U01HL10039NHLBI NIH HHS U01 HL100397
6 · The paper itself

Abstract

Endothelial cells (ECs) are aligned longitudinally under laminar flow, whereas they are polygonal and poorly aligned in regions of disturbed flow. The unaligned ECs in disturbed flow fields manifest altered function and reduced survival that promote lesion formation. We demonstrate that the alignment of the ECs may directly influence their biology, independent of fluid flow. We developed aligned nanofibrillar collagen scaffolds that mimic the structure of collagen bundles in blood vessels, and examined the effects of these materials on EC alignment, function, and in vivo survival. ECs cultured on 30-nm diameter aligned fibrils re-organized their F-actin along the nanofibril direction, and were 50% less adhesive for monocytes than the ECs grown on randomly oriented fibrils. After EC transplantation into both subcutaneous tissue and the ischemic hindlimb, EC viability was enhanced when ECs were cultured and implanted on aligned nanofibrillar scaffolds, in contrast to non-patterned scaffolds. ECs derived from human induced pluripotent stem cells and cultured on aligned scaffolds also persisted for over 28 days, as assessed by bioluminescence imaging, when implanted in ischemic tissue. By contrast, ECs implanted on scaffolds without nanopatterning generated no detectable bioluminescent signal by day 4 in either normal or ischemic tissues. We demonstrate that 30-nm aligned nanofibrillar collagen scaffolds guide cellular organization, modulate endothelial inflammatory response, and enhance cell survival after implantation in normal and ischemic tissues.

Indexed as

AnimalsAnisotropyCattleCell AdhesionCell ShapeCell SurvivalCoculture TechniquesCollagenEndothelial CellsHindlimbHumansIschemiaMaleMembranes, ArtificialMiceMyocytes, Smooth MuscleCollagenMembranes, Artificial

Identifiers

PMID23480958
PMCPMC3695739
OpenAlexW2023506111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.